Keyword: Chris Viehbacher
News
10.02.2011
- Sanofi Aventis Chief Executive Chris Viehbacher said in an interview that the French pharmaceuticals group's offer for Genzyme could be extended for a third time, beyond the Feb...
News
07.02.2011
- The boards of Sanofi-Aventis SA and Genzyme Corp were scheduled to hold separate meetings on Sunday to discuss a potential deal, but talks may linger into the week, sources...
News
03.02.2011
- French drugmaker Sanofi-Aventis could announce a deal to buy U.S. biotech Genzyme early next week if final negotiations between the companies go smoothly, Le Figaro reported on...
News
02.02.2011
- France's Sanofi-Aventis has agreed to raise its bid for Genzyme Corp to the low $70s-per-share range, plus a milestone payment based on the performance of an experimental drug, a...
News
01.02.2011
- U.S. biotech Genzyme and French drugmaker Sanofi-Aventis have reached agreement in principle on the terms of a deal under which Sanofi would acquire Genzyme, three sources familiar...
News
31.01.2011
- Dealmaking is back on the agenda as CEOs step up the hunt for ways to put a multitrillion-dollar cash pile to work, triggering the busiest January for M&A in 11 years. There is...
News
27.01.2011
- A proxy battle for control of Genzyme is unlikely, given the progress being made in discussions with Sanofi-Aventis, the U.S. biotech group's chief executive said on Thursday...
News
27.01.2011
- Sanofi-Aventis has made progress in talks with U.S. bid target Genzyme and leaders of both companies may bump into each other in Davos this week, Sanofi's CEO said on Wednesday...
